Last reviewed · How we verify
haloperidole
At a glance
| Generic name | haloperidole |
|---|---|
| Sponsor | Janssen Scientific Affairs, LLC |
| Modality | Small molecule |
| Therapeutic area | Other |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- 15 Month Study for Adults Who Have Been Diagnosed With Schizophrenia and Incarcerated (PHASE4)
- Twelve Month Study Comparing Paliperidone Palmitate and Select Oral Antipsychotics in Adults With Schizophrenia Who Have Been Recently Discharged From an Inpatient Psychiatric Hospital (PHASE4)
- Discontinuation of Antipsychotics and Antidepressants Among Patients With BPSD (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |